PDL
GILD icon

Portfolio Design Labs’s Gilead Sciences GILD Stock Holding History

Portfolio Design Labs’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.37M Sell
9,837
-2,542
-21% -$356K 0.24% 81
2025
Q4 		$1.52M Buy
12,379
+231
+2% +$28.1K 0.25% 100
2025
Q3 		$1.35M Buy
+12,148
New +$1.38M 0.23% 116
2024
Q1 		– Sell
-3,660
Closed -$296K – 124
2023
Q4 		$296K Buy
+3,660
New +$285K 0.11% 98

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Portfolio Design Labs's GILD Position: Q1 2026 in Review

Portfolio Design Labs reduced its Gilead Sciences (GILD) stake by 21% in Q1 2026, selling an estimated $356K and leaving 9,837 shares worth $1.37M. The position accounts for 0.24% of the portfolio, ranked #81.

Portfolio Design Labs first reported a position in GILD in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.52M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Portfolio Design Labs held 9,837 shares of Gilead Sciences worth $1.37M as of Q1 2026.
  • Portfolio Design Labs sold 2,542 Gilead Sciences shares in Q1 2026, an estimated $356K.
  • Gilead Sciences made up 0.24% of Portfolio Design Labs's portfolio in Q1 2026, its #81 holding.
  • Portfolio Design Labs first reported a position in Gilead Sciences in Q4 2023 and has held it in 4 quarters since.
  • Portfolio Design Labs's Gilead Sciences position peaked at $1.52M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Portfolio Design Labs's 13F filing for Q1 2026, filed 11 May 2026.